- Home
- VISN vs CLDX Comparison
VISN vs CLDX Comparison
Compare VISN & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VISN | CLDX |
|---|---|---|
| Founded | 1976 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 3.0B |
| IPO Year | 2013 | 1995 |
Fundamental Metrics
Financial Performance| Metric | VISN | CLDX |
|---|---|---|
| Price | $6.48 | $37.89 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 10 |
| Target Price | $21.00 | ★ $46.60 |
| AVG Volume (30 Days) | ★ 8.2M | 642.3K |
| Earning Date | 04-30-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 641.01 | N/A |
| EPS | ★ 24.79 | N/A |
| Revenue | ★ $1,931,600,000.00 | $12,743,000.00 |
| Revenue This Year | $9.44 | $111.39 |
| Revenue Next Year | $5.91 | $235.85 |
| P/E Ratio | $0.26 | ★ N/A |
| Revenue Growth | N/A | ★ 87.78 |
| 52 Week Low | $6.00 | $22.10 |
| 52 Week High | $19.91 | $45.14 |
Technical Indicators
Market Signals| Indicator | VISN | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 29.91 | 44.75 |
| Support Level | $6.00 | $36.84 |
| Resistance Level | $12.59 | $40.30 |
| Average True Range (ATR) | 0.22 | 1.55 |
| MACD | 0.11 | -0.15 |
| Stochastic Oscillator | 56.94 | 28.14 |
Price Performance
Historical ComparisonAbout VISN Vistance Networks Inc. Common Stock
Vistance Networks Inc operates in the communications technology sector, providing solutions designed to support the delivery and management of communications services. It serves customers globally through teams involved in product development, implementation, and customer support. The company designs and develops network infrastructure and connectivity solutions focused on reliability and performance. Its offerings include intelligent networking technologies intended to support evolving communication requirements.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.